- Home
- EDRY vs NVNO Comparison
EDRY vs NVNO Comparison
Compare EDRY & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDRY
- NVNO
- Stock Information
- Founded
- EDRY 2018
- NVNO 1987
- Country
- EDRY Greece
- NVNO United States
- Employees
- EDRY N/A
- NVNO N/A
- Industry
- EDRY Marine Transportation
- NVNO Medical/Dental Instruments
- Sector
- EDRY Consumer Discretionary
- NVNO Health Care
- Exchange
- EDRY Nasdaq
- NVNO Nasdaq
- Market Cap
- EDRY 57.9M
- NVNO 59.4M
- IPO Year
- EDRY N/A
- NVNO N/A
- Fundamental
- Price
- EDRY $15.49
- NVNO $3.28
- Analyst Decision
- EDRY Strong Buy
- NVNO
- Analyst Count
- EDRY 1
- NVNO 0
- Target Price
- EDRY $30.00
- NVNO N/A
- AVG Volume (30 Days)
- EDRY 6.4K
- NVNO 96.4K
- Earning Date
- EDRY 11-19-2024
- NVNO 10-31-2024
- Dividend Yield
- EDRY N/A
- NVNO N/A
- EPS Growth
- EDRY N/A
- NVNO N/A
- EPS
- EDRY N/A
- NVNO N/A
- Revenue
- EDRY $57,770,014.00
- NVNO N/A
- Revenue This Year
- EDRY $59.92
- NVNO N/A
- Revenue Next Year
- EDRY $14.08
- NVNO N/A
- P/E Ratio
- EDRY N/A
- NVNO N/A
- Revenue Growth
- EDRY 9.80
- NVNO N/A
- 52 Week Low
- EDRY $14.62
- NVNO $3.01
- 52 Week High
- EDRY $24.84
- NVNO $6.97
- Technical
- Relative Strength Index (RSI)
- EDRY 27.48
- NVNO 39.99
- Support Level
- EDRY $14.62
- NVNO $3.25
- Resistance Level
- EDRY $15.80
- NVNO $3.68
- Average True Range (ATR)
- EDRY 0.68
- NVNO 0.15
- MACD
- EDRY -0.11
- NVNO 0.03
- Stochastic Oscillator
- EDRY 22.63
- NVNO 9.20
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulks such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).